The day to day price is totally irrelevant. If IHL create a genuine drug in any of the six current clinical sectors then you won’t be able to hose this share price down. OSA already looks like it’s heading in the right direction, as is ARDS.
I’m actually stunned by the continued short term thinking on these threads.
In more than 20 years I’ve never invested in a stock with this much upside potential combined with a board that can actually deliver.
IHL Price at posting:
42.5¢ Sentiment: Buy Disclosure: Held